glp-1 heart rate Differential effects of glucagon-like peptide-1 receptor agonists on | Cardiovascular Diabetology GLP-1 Agonists in Cardiovascular Diseases:
Description
Similarly, Lincoff et al59 conducted an RCT enrolling 17,604 patients aged 45 years or older with pre-existing cardiovascular disease and a BMI of 27 or higher but without a history of diabetes
Think of it as the onboarding phase
Opportunity Why is the Growing Applications of GLP-1 Drugs an Opportunity in the GLP-1 Drugs Market
doi: 10.2337/dc19-0749 222 RosenstockJWyshamCFrasJPKanekoSLeeCJFernndez LandLet al
Its savvy too: Some surveys have found the medications may lead to an uptick in gym memberships
